| INTRODUCTION
Atrial fibrillation (AF) is one of the commonest cardiac arrhythmias encountered in clinical practice, related to considerable cardiovascular morbidity and mortality. The association between inflammation and the development of AF is well recognized. Thus, different inflammatory biomarkers have been implicated in AF while anti-inflammatory upstream therapies may reduce AF burden. In this context, high sensitivity Creactive protein (hs-CRP) levels have been associated with a higher risk of AF recurrence after electrical cardioversion 1, 2 as well as after catheter ablation. 3 Red blood cell distribution width (RDW) is a quantitative measure of variability of the size of circulating red blood cells. It can aid clinicians in the differential diagnosis of anemia. 4 This is now routinely reported in complete blood count (CBC) tests and is readily available in hospital care settings. Elevated RDW has been observed in proinflammatory conditions. 5, 6 Of note, several studies have reported higher RDW levels as a strong independent predictor of morbidity and mortality in various cardiovascular disease states. [7] [8] [9] [10] [11] [12] [13] [14] Interestingly, several studies have reported on the association between RDW and the development of AF. [15] [16] [17] Given that some controversial results have been published, we aimed to conduct a systematic review and meta-analysis to further elucidate the relationship between RDW and AF development.
| METHODS

| Search strategies and selection criteria
PubMed, Ovid, Embase, and Web of Science were systematically and independently searched by two reviewers (Q. S. and T.L.) up to June 2016 to identify relevant articles evaluating the association between RDW and AF development. The search items were "red blood cell distribution width," "RDW," and "atrial fibrillation." Additionally, a manual search was conducted in Abstract books of the scientific sessions of the American College of Cardiology (ACC), the American Heart Association (AHA), and the European Society of Cardiology (ESC) over the past 5 years.
The inclusion criteria were as follows: (1) a prospective cohort study, retrospective cohort study, or case-control study; (2) RDW levels and clinical outcomes during follow-up were documented; (3) the potential association between RDW levels and AF development was examined; (4) diagnosis of AF was clearly defined in accordance with current guideline-based definitions. Published studies without language restriction were included.
| Data extraction
All entries were independently reviewed by two reviewers (Q.
S. and T.L.) for compliance with the inclusion criteria. Potentially relevant reports were then retrieved as complete manuscripts and assessed for compliance with the inclusion criteria using a standardized form. A third reviewer (G.L.) was consulted for uncertainties or discrepancies between the two reviewers. These were then resolved by majority opinion among three reviewers. The mean and standard deviation (SD) of RDW in AF group and no-AF group were extracted. If the study provided medians and interquartile ranges instead of means and SDs, we computed the means and SDs as previously described. 18 The lower end of the range was calculated by (upper quartile − lower quartile)/2 − median, whereas the upper end of the range was calculated by (upper quartile − lower quartile)/2 + median. The following data were extracted from studies that met the inclusion criteria: first author's last name, publication year, study design, study population, sample size, gender, age, follow-up duration, methods for AF detection, and postoperative AF rates.
| Quality assessment
To reduce the heterogeneity due to different study designs, the quality of each study was evaluated based on the United States Studies meeting <5 criteria were graded as poor, those meeting 5-7 criteria were regarded as fair, and those meeting ≥8 criteria were graded as good. 
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| Statistical analysis
Standardized effect sizes were derived by dividing the mean difference of RDW levels between AF and no-AF groups of each study by its SD. Heterogeneity was measured by Cochran's Q statistic and the inconsistency index (I 2 ). P < .05 for the Cochran's Q and an I 2 >50%
indicate the presence of moderate statistical heterogeneity. A fixedeffects model was used when I 2 < 50%, otherwise the random-effects model was used. Sensitivity analysis that performed in a random, predefined manner was used to investigate the influence of a single study on the overall risk estimate and was carried out by sequentially excluding one study at a time. Subgroup analysis was performed on the study design (cohort study or case-control study), duration of follow-up (≥3 months or <3 months), study population (postoperative AF or other AF), and sample size (<200 or ≥200). Publication bias was assessed by funnel plot analysis. A two-tailed P-value < .05 was considered statistically significant. All statistical analyses were performed using STATA 11 (Stata Corp LP, College Station, TX, USA).
| RESULTS
| Literature search
The search strategy and study selection process are detailed in Figure 1 . A total of 174 studies were initially found using our search criteria while 23 duplicate studies were identified and subsequently excluded. The remaining 151 studies were further screened, and 135 studies were excluded, because they were either unrelated, irrelevant, review articles, or editorials. Then full-text studies were retrieved for detailed evaluation. Of the remaining 16 articles, one study 21 examined the association between AF and CHA2DS2-VASc, two 22, 23 predicted long-term prognosis in patients with AF, and one 24 did not offer mean ± SD of RDW in AF group and no-AF group, and therefore were excluded. The remaining 12 studies [15] [16] [17] [25] [26] [27] [28] [29] [30] [31] [32] [33] were finally included in our meta-analysis.
| Description of included studies
A total of 12 studies involving 2721 patients were finally included in the analysis. The main features of the studies are presented in 
| Main analysis
Red blood cell distribution width levels were higher in patients 95% confidence interval 0.33-0.88; P < .05) with significant heterogeneity across studies (P < .01; I 2 = 80.7%) ( Figure 3 and Table 2 ).
| Sensitivity and subgroup analysis
Sensitivity and subgroup analyses were performed to identify the origin of heterogeneity. After removing one study 25 with a sample size of <50 cases, the analysis did not find a significant influence on the pooled effect estimates. A predefined subgroup analyses were performed according to study design (prospective or retrospective cohort and case-control), study population, follow-up period, geographic area, and sample size ( Table 2 ). The likely origin of the observed heterogeneity is geographic area and follow-up period.
| Publication bias
The findings of the funnel plot for the association baseline RDW and AF development were symmetrical, indicating the potential for no publication bias (P = .193) (Figure 4 ).
| DISCUSSION
Red blood cell distribution width (RDW) is a quantitative measure of variability in the size of circulating red blood cells. Its assessment has been used to aid clinicians in the differential diagnosis of anemia. In complete blood count (CBC) tests, RDW is routinely provided and it is convenient for use in clinical practice. Previous studies have reported that higher RDW levels as a strong independent predictor of increased morbidity and mortality in patients with acute and chronic heart failure, 7-10 myocardial infarction, 11, 12 and after coronary artery bypass grafting 13 or coronary angiography 14 The mechanisms between elevated RDW levels and poor clinical outcomes in cardiovascular diseases have not yet been fully understood. 34 First, recent studies indicate that high levels of RDW may reflect a pro-inflammatory state 5, 6 Indeed, the release of proinflammatory cytokines can suppress erythropoietin-induced red cell maturation, and then, higher numbers of immature red cells can produce higher RDW levels. 35 Secondly, Patel et al 36 proposed that increased erythrocyte life span, with lower MCV and higher RDW, could be a fundamental response to disease. Another possible explanation could be that erythrocytes that have been circulating for a long time (old erythrocytes are smaller, which increased RDW) has deteriorated enzyme systems, which lost some of their anti-oxidative functions.
Several pathophysiological processes, such as oxidative stress and pro-inflammatory environment, can increase RDW levels through reducing red blood cell survival, thereby producing a more mixed population of erythrocytes in the circulation.
Atrial fibrillation is a prevalent medical condition affecting a significant percentage of the population, with an increasing prevalence with age. It increases the risk of stroke and death. An increasing 
| Study limitations
The following limitations of this study should be noted. Firstly, RDW was assessed in different laboratories, and different interquartile range values used in each study were a possible cause of heterogeneity observed. Secondly, lack of repeated measurements of RDW was observed in some studies. Thirdly, the meta-analyses showed a significant association between baseline RDW and AF occurrence/recurrence after cardiac procedure or surgery. However, due to incomplete provided data, an association between levels of postoperative RDW and AF risk was not observed, and therefore, additional studies are needed to further clarify this issue. Finally, we did not evaluate the relative value of other inflammatory biomarkers along with RDW in the setting of AF.
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